Mårten Fernö

Researcher
More filtering options
  1. 1999
  2. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer

    Rudolph, P., P Alm, Heidebrecht, H. J., Bolte, H., Ratjen, V., B Baldetorp, M Fernö, H Olsson & Parwaresch, R., 1999 Feb 3, In : Journal of the National Cancer Institute. 91, 3, p. 271-8 8 p.

    Research output: Contribution to journalArticle

  3. 1998
  4. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group

    Bo Baldetorp, Stal, O., Ahrens, O., Cornelisse, C., Corver, W., Falkmer, U. & Mårten Fernö, 1998, In : Cytometry. 33, 4, p. 385-393

    Research output: Contribution to journalArticle

  5. Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene

    Tanner, M. M., Karhu, R. A., Nupponen, N. N., Åke Borg, Bo Baldetorp, Pejovic, T., Mårten Fernö, Dick Killander & Isola, J., 1998, In : American Journal of Pathology. 153, 1, p. 191-199

    Research output: Contribution to journalArticle

  6. 1997
  7. Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples--a Swedish multicenter study. Swedish Society of Cancer Study Group

    Mårten Fernö, Pär-Ola Bendahl, Brisfors, A., Byman, K., Ekeberg, M., Ferraud, L., Grankvist, K., Hjalmers, B., Nilsson, A., Sellberg, G., Skoog, L., Stal, O. & Wingmo, I., 1997, In : Acta Oncologica. 36, 8, p. 793-798

    Research output: Contribution to journalArticle

  8. 1996
  9. Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility

    Gudmundsson, T. E., Långström-Einarsson, E., Per Alm, Anderson, H., Bo Baldetorp, Mårten Fernö, Thomas Högberg & Dick Killander, 1996, In : Acta Oncologica. 35, 8, p. 999-1006

    Research output: Contribution to journalArticle

  10. 1995
  11. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates

    Bo Baldetorp, Pär-Ola Bendahl, Mårten Fernö, Alanen, K., Delle, U., Falkmer, U., Hansson-Aggesjö, B., Hockenström, T., Lindgren, A., Mossberg, L., Nordling, S., Sigurdsson, H., Stål, O. & Visakorpi, T., 1995, In : Cytometry. 22, 2, p. 115-127

    Research output: Contribution to journalArticle

  12. The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma

    Gudmundsson, T. E., Thomas Högberg, Per Alm, Anderson, H., Bo Baldetorp, Mårten Fernö, Langström, E. & Dick Killander, 1995, In : Acta Oncologica. 34, 6, p. 803-812

    Research output: Contribution to journalArticle

  13. 1994
  14. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group

    Mårten Fernö, Bo Baldetorp, Åke Borg, Brouillet, J. P., Håkan Olsson, Rochefort, H., Sellberg, G., Sigurdsson, H. & Dick Killander, 1994, In : European Journal of Cancer. 30a, 14, p. 2042-2048

    Research output: Contribution to journalArticle

  15. Inter-institutional reproducibility of flow cytometric DNA-analysis in breast carcinomas

    Risberg, B., Bo Baldetorp, Mårten Fernö, Hansson, B., Mossberg, L. L., Roos, G., Stal, O., Thornthwaite, J. T. & Tibell, L., 1994, In : Analytical Cellular Pathology. 6, 1, p. 23-36

    Research output: Contribution to journalArticle

  16. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?

    Choong, P. F., Åkerman, M., Willen, H., Andersson, C., Gustafson, P., Bo Baldetorp, Mårten Fernö, Thor Alvegård & Anders Rydholm, 1994, In : APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 102, 12, p. 915-924

    Research output: Contribution to journalArticle

  17. 1993
  18. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix

    Willen, R., Himmelmann, A., Långström-Einarsson, E., Mårten Fernö, Jonas Ranstam, Bo Baldetorp, Skjaerris, J., Prien-Larsen, J., Trope, C. & Stendahl, U., 1993, In : Anticancer research. 13, 4, p. 1187-1196

    Research output: Contribution to journalArticle

  19. T3N0 glottic carcinoma: DNA S-phase as a predictor of the outcome after radiotherapy

    Jan Tennvall, Johan Wennerberg, Willen, R., Ask, A., Bo Baldetorp & Mårten Fernö, 1993, In : Acta Oto-Laryngologica. 113, 1, p. 220-224

    Research output: Contribution to journalArticle

  20. 1992
  21. Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer

    Ewers, S-B., Attewell, R., Bo Baldetorp, Åke Borg, Mårten Fernö, Långström-Einarsson, E., Ryden, S. & Dick Killander, 1992, In : Acta Oncologica. 31, 7, p. 733-740

    Research output: Contribution to journalArticle

  22. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

    Bo Baldetorp, Mårten Fernö, Fallenius, A., Fallenius-Vecchi, G., Idvall, I., Håkan Olsson, Sigurdsson, H., Åkerman, M. & Dick Killander, 1992, In : Cytometry. 13, 6, p. 577-585

    Research output: Contribution to journalArticle

  23. One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

    Mårten Fernö, Bo Baldetorp, Ewers, S-B., Idvall, I., Håkan Olsson, Sigurdsson, H. & Dick Killander, 1992, In : Cytometry. 13, 3, p. 241-249

    Research output: Contribution to journalArticle

  24. 1991
  25. Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.

    H. Olsson, A. Borg, M. Fernö, Möller, T. R. & Ranstam, J., 1991 Dec 1, In : Cancer Detection and Prevention. 15, 4, p. 265-271

    Research output: Contribution to journalArticle

  26. DNA ploidy assessment of breast milk (colostrum) in primiparous women of different ages

    Håkan Olsson, Lindahl, B., Bo Baldetorp, Åke Borg, Mårten Fernö, Dick Killander & Ranstam, J., 1991 Jul 1, In : Breast Disease. 4, 3, p. 219-222

    Research output: Contribution to journalArticle

  27. Association of int2/hst1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis

    A. Borg, Sigurdsson, H., Clark, G. M., M. Ferno, Fuqua, S. A. W., H. Olsson, D. Killander & McGurie, W. L., 1991 Jan 1, In : British Journal of Cancer. 63, 1, p. 136-142

    Research output: Contribution to journalArticle

  28. Correspondence and Short Communications: Estrogen receptors in gastric cancer

    Jan Johansson, Thulin, L., M Fernö & Andrén-Sandberg, A., 1991, In : Acta oncologica (Stockholm, Sweden). 30, 7, p. 870-2 3 p.

    Research output: Contribution to journalArticle

  29. ERBB2 amplification in breast cancer with a high rate of proliferation

    Åke Borg, Bo Baldetorp, Mårten Fernö, Dick Killander, Håkan Olsson & Sigurdsson, H., 1991, In : Oncogene. 6, 1, p. 137-143

    Research output: Contribution to journalArticle

  30. Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions

    Håkan Olsson, Ranstam, J., Bo Baldetorp, Ewers, S-B., Mårten Fernö, Dick Killander & Sigurdsson, H., 1991, In : Cancer. 67, 5, p. 1285-1290

    Research output: Contribution to journalArticle

  31. 1990
  32. Estrogen and progesterone receptor analyses in more than 4000 human breast cancer samples: A study with special reference to age at diagnosis and stability of analyses

    M. Fernö, Å Borg, Johansson, U., Norgren, A., H. Olsson, Rydén, S., Sellberg, G. & Southern Swedish Breast Cancer Study Group, 1990 Jan 1, In : Acta Oncologica. 29, 2, p. 129-135

    Research output: Contribution to journalArticle

  33. Prognostic indicators in node-negative breast cancer (Reply)

    Sigurdsson, H., B. Baldetorp, A. Borg, M. Ferno, D. Killander & H. Olsson, 1990 Jan 1, In : New England Journal of Medicine. 323, 19, p. 1349-1350 2 p.

    Research output: Contribution to journalLetter